BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34781805)

  • 1. Efficacy of Infliximab in Disease Control of Refractory Orbital Myositis.
    El Nokrashy A; Lightman S; Tomkins-Netzer O
    Ocul Immunol Inflamm; 2023 Jan; 31(1):153-157. PubMed ID: 34781805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab.
    Sahlin S; Lignell B; Williams M; Dastmalchi M; Orrego A
    Acta Ophthalmol; 2009 Nov; 87(8):906-8. PubMed ID: 18631325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature.
    Verma S; Kroeker KI; Fedorak RN
    BMC Gastroenterol; 2013 Apr; 13():59. PubMed ID: 23556424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab Reverses Symptoms and May Protect from Developing Chronic Restrictive Ophthalmopathy in Children with Familial Orbital Myositis: A Case Report.
    Huynh A; Siggs OM; Wainstein BK; Gray PE
    Ocul Immunol Inflamm; 2023 Jul; 31(5):1097-1100. PubMed ID: 35622932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic orbital myositis.
    Yan J; Wu P
    J Craniofac Surg; 2014 May; 25(3):884-7. PubMed ID: 24670274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostics and treatment of orbital myositis.
    Pidro A; Dizdarević A; Jovanović N; Čerim A; Sačak E; Miokovic AP
    Rom J Ophthalmol; 2022; 66(2):173-177. PubMed ID: 35935078
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral diffuse orbital myositis in a patient with relapsing ulcerative colitis.
    Bennion J; Harris MA; Sivak-Callcott JA; Nguyen J
    Ophthalmic Plast Reconstr Surg; 2012; 28(5):e119-20. PubMed ID: 22366668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab as an alternative for corticosteroid-refractory orbital myositis.
    Meca Casasnovas N; Sangrador Pelluz C; Sotoca J
    J Neuroimmunol; 2021 Jul; 356():577573. PubMed ID: 33933820
    [No Abstract]   [Full Text] [Related]  

  • 9. Orbital inflammation following COVID-19 vaccination: A case series and literature review.
    Ang T; Tong JY; Patel S; Khong JJ; Selva D
    Int Ophthalmol; 2023 Sep; 43(9):3391-3401. PubMed ID: 37198501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital myositis: diagnosis and management.
    Costa RM; Dumitrascu OM; Gordon LK
    Curr Allergy Asthma Rep; 2009 Jul; 9(4):316-23. PubMed ID: 19656480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab.
    Garrity JA; Coleman AW; Matteson EL; Eggenberger ER; Waitzman DM
    Am J Ophthalmol; 2004 Dec; 138(6):925-30. PubMed ID: 15629282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature.
    Avni-Zauberman N; Tripathy D; Rosen N; Ben Simon GJ
    Br J Ophthalmol; 2012 Feb; 96(2):276-80. PubMed ID: 21527417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital myositis associated with discoid lupus erythematosus.
    Kono S; Takashima H; Suzuki D; Terada T; Konishi T; Miyajima H
    Lupus; 2014 Feb; 23(2):220-2. PubMed ID: 24335011
    [No Abstract]   [Full Text] [Related]  

  • 15. Orbital Myositis: A Comprehensive Review and Reclassification.
    McNab AA
    Ophthalmic Plast Reconstr Surg; 2020; 36(2):109-117. PubMed ID: 31261163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rationale for a diagnostic approach in non-Graves' orbital inflammation--Report of 61 patients].
    Gavard-Perret A; Lagier J; Delmas J; Delas J; Adenis JP; Robert PY
    J Fr Ophtalmol; 2015 Dec; 38(10):912-23. PubMed ID: 26604081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of idiopathic orbital inflammation with infliximab: an alternative to conventional steroid-sparing agents.
    Miquel T; Abad S; Badelon I; Vignal C; Warzocha U; Larroche C; Morax S; Dhote R
    Ophthalmic Plast Reconstr Surg; 2008; 24(5):415-7. PubMed ID: 18806671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab "Top-Down" Strategy is Superior to "Step-Up" in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease.
    Lee YM; Kang B; Lee Y; Kim MJ; Choe YH
    J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):737-43. PubMed ID: 25564801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital myositis in a patient with Crohn's disease: A case report of two episodes.
    Oliver-Gutierrez D; Garrido-Marin M; Segura-Duch G; Alonso T; Ros-Sanchez E; Oliveres J
    J Fr Ophtalmol; 2024 Apr; 47(4):104048. PubMed ID: 38238142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.